Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human SRD5A1 ELISA Kit (AC3827)
Cat.#: ASET-2416
Specifications
Description Human SRD5A1 ELISA Kit allows for the in vitro quantitative determination of human SRD5A1 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.094 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.156-10 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1377 Rat Adiponectin ELISA Kit (AC2788) Quantitative inquiry ASET-1674 Mouse Angiogenin ELISA Kit (AC3085) Quantitative inquiry ASET-1772 Rat Prealbumin ELISA Kit (AC3183) Quantitative inquiry ASET-1348 Human Luteinizing Hormone ELISA Kit (AC2759) Quantitative inquiry ASET-1478 Mouse Mitofusin 2 ELISA Kit (AC2889) Quantitative inquiry ASET-2496 Human KAL1 ELISA Kit (AC3907) Quantitative inquiry ASET-1079 Human Synapsin I ELISA Kit (AC2490) Quantitative inquiry ASET-1332 Human Somatostatin Receptor 2 ELISA Kit (AC2743) Quantitative inquiry ASET-1302 Mouse Laminin alpha 1 ELISA Kit (AC2713) Quantitative inquiry ASET-1968 Mouse EGR3 ELISA Kit (AC3379) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket